Biotech and pharma 2023 winners and losers list

I hate end-of-the-year pieces. They tend to be dull and assigned by some editor who sees the odometer rolling over and thinks that’s more interesting than actual news.

But part of the gig at Endpoints News is keeping tabs on who’s ?? and who’s ??, which strategies and mechanisms are…
Click here to view original post